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Timing of in utero malaria exposure 
influences fetal CD4 T cell regulatory 
versus effector differentiation
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Mayimuna Nalubega3, Kenneth Musinguzi3, Kate Naluwu3, Esther Sikyoma3, Rachel Budker2, Hilary Vance2, 
Pamela Odorizzi2, Patience Nayebare3, John Ategeka3, Abel Kakuru3, Diane V. Havlir2, Moses R. Kamya4, 
Grant Dorsey2 and Margaret E. Feeney1,2*
Abstract 
Background: In malaria-endemic areas, the first exposure to malaria antigens often occurs in utero when the 
fetal immune system is poised towards the development of tolerance. Children exposed to placental malaria have 
an increased risk of clinical malaria in the first few years of life compared to unexposed children. Recent work has 
suggested the potential of pregnancy-associated malaria to induce immune tolerance in children living in malaria-
endemic areas. A study was completed to evaluate the effect of malaria exposure during pregnancy on fetal immune 
tolerance and effector responses.
Methods: Using cord blood samples from a cohort of mother-infant pairs followed from early in pregnancy until 
delivery, flow cytometry analysis was completed to assess the relationship between pregnancy-associated malaria 
and fetal cord blood CD4 and dendritic cell phenotypes.
Results: Cord blood FoxP3+ Treg counts were higher in infants born to mothers with Plasmodium parasitaemia 
early in pregnancy (12–20 weeks of gestation; p = 0.048), but there was no association between Treg counts and 
the presence of parasites in the placenta at the time of delivery (by loop-mediated isothermal amplification (LAMP); 
p = 0.810). In contrast, higher frequencies of activated CD4 T cells (CD25+FoxP3−CD127+) were observed in the 
cord blood of neonates with active placental Plasmodium infection at the time of delivery (p = 0.035). This popula-
tion exhibited evidence of effector memory differentiation, suggesting priming of effector T cells in utero. Lastly, 
myeloid dendritic cells were higher in the cord blood of infants with histopathologic evidence of placental malaria 
(p < 0.0001).
Conclusion: Together, these data indicate that in utero exposure to malaria drives expansion of both regulatory and 
effector T cells in the fetus, and that the timing of this exposure has a pivotal role in determining the polarization of 
the fetal immune response.
Keywords: Pregnancy-associated malaria, Fetal immune response, Immune tolerance, CD4 T cells, Dendritic cells, 
Loop-mediated isothermal amplification
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Malaria Journal
*Correspondence:  Margaret.feeney@ucsf.edu 
1 Department of Pediatrics, University of California-San Francisco, 3333 
California Street, Suite 315, Box 1234, San Francisco, CA 94143, USA
Full list of author information is available at the end of the article
Page 2 of 10Prahl et al. Malar J  (2016) 15:497 
Background
More than 12.4 million pregnancies occur annually in 
regions at risk of malaria transmission [1], and one in four 
pregnant women in sub-Saharan Africa have evidence 
of infection with malaria at parturition [2]. Pregnancy-
associated malaria results in tremendous obstetrical and 
paediatric morbidity, including maternal anaemia, intra-
uterine growth retardation, low birth weight, prema-
turity, miscarriage, and stillbirth. It has been estimated 
that pregnancy-associated malaria causes 100,000 infant 
deaths per year [2]. In addition to these immediate con-
sequences, exposure to malaria antigens in utero may 
influence the developing fetal immune system in ways 
that remain poorly defined.
Several studies have reported that infants born to 
mothers with placental malaria (PM) are themselves at 
higher risk for malaria during the first few years of life [3–
5]. While this may be due in part to the fact that mothers 
and their infants experience similar levels of exposure 
to infected mosquitoes, recent studies suggest that tol-
erance to malaria antigens may be induced following 
exposure in utero [6–13], suggesting a potential immu-
nologic explanation for this association. Infant T cells are 
uniquely predisposed toward the induction of tolerance 
upon encounter with foreign antigens, presumably as a 
result of the requirement to maintain maternal-fetal tol-
erance [14]. In malaria-endemic areas, many infants are 
first exposed to malaria antigens in utero, during a criti-
cal period of fetal immune development. In utero expo-
sure to malaria has been reported to induce numerous 
immunoregulatory mechanisms in the fetus, including 
expansion of FoxP3+ T regulatory cells, increased levels 
of suppressive cytokines such as IL-10 and TGF-β and 
diminished CD4 Th1 responses [6, 7, 10, 12, 13]. Moreo-
ver, one study found that some exposed infants acquire 
a tolerant phenotype that is associated with an increased 
risk of malaria infection later in childhood [6]. While it is 
widely accepted that CD4 T cells in the neonate respond 
differently to antigen compared to adults [15], includ-
ing skewing toward Th2 and Treg differentiation [16], the 
biologic mechanisms underlying these differences are 
unclear. These differences may arise from T cell-intrinsic 
factors, such as epigenetic programming [17] or differ-
ences in fetal haematopoietic stem-progenitor cells [16], 
or as a result of insufficient priming by immature den-
dritic cells.
Prior studies comparing cord blood CD4 T regula-
tory cell (Treg) frequencies in infants with and without in 
utero malaria exposure have yielded conflicting results. 
Some studies have observed higher frequencies of Tregs 
in placenta malaria-exposed infants [9–11], while oth-
ers have not [7, 8, 12]. This may be due to several factors. 
First, past studies differ in their gating strategies to quan-
tify Tregs, with earlier studies including all CD25+ CD4 T 
cells, while later studies used more stringent definitions 
including expression of the transcription factor FoxP3 
and/or low expression of CD127. PM diagnosis and cate-
gorization also differed in prior studies. Most were cross-
sectional and evaluated for malaria infection only at the 
time of delivery, a strategy that may have missed maternal 
infections that occurred earlier in pregnancy. Finally, PM 
was diagnosed in some studies based on placental blood 
smear while others used more sensitive histopathologic 
criteria. To date, no studies have assessed the relationship 
of cord blood regulatory CD4 T cell frequencies to pla-
cental infection using sensitive nucleic acid tests for Plas-
modium falciparum.
This study evaluated the impact of in utero malaria 
exposure on the frequency and phenotype of CD4 T reg-
ulatory cells and dendritic cells, using cord blood samples 
from infants born in a highly malaria-endemic region of 
Uganda. Mother-infant pairs were followed longitudi-
nally beginning from 12 to 20  weeks gestation through 
delivery. CD4 T cells were compared in infants born 
to mothers with and without evidence of Plasmodium 
infection during pregnancy to test the hypothesis that in 
utero malaria exposure would result in an expansion of 
fetal regulatory CD4 T cells and/or effector CD4 T cells.
Methods
Ethical approval
Informed consent was obtained from the parent or 
guardian of all study participants. The study protocol 
was approved by the Uganda National Council of Science 
and Technology (UNCST), and the institutional review 
boards of the University of California, San Francisco 
(UCSF) and Makerere University.
Study site and participants
Samples were collected from a clinical trial of prenatal 
malaria chemoprevention conducted in Tororo, Uganda, 
an area of high malaria endemicity. Clinical trial out-
comes are described in a prior publication [18]. Briefly, 
300 HIV-negative mother-infant pairs were enrolled 
between 12 and 20 weeks of gestation (June to October 
2014). Study clinicians performed ultrasound dating on 
all participants to determine gestational age at the time 
of enrolment. Evaluated enrollees were randomized to 
standard malaria chemoprevention (three-dose sulfadox-
ine-pyrimethamine) versus enhanced malaria chemo-
prevention (monthly dihydroartemisinin-piperaquine) 
from which sufficient cord blood mononuclear cells 
(CBMCs) were available. Participants randomized to 
the standard chemoprevention arm were administered 
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sulfadoxine-pyrimethamine at 20, 28 and 36  weeks of 
gestation. Participants randomized to the monthly dihy-
droartemisinin-piperaquine arm received drug every 
4  weeks beginning at 16 or 20  weeks based on gesta-
tional age at enrolment. At enrolment, study participants 
received an insecticide-treated bed net. All mothers 
received one dose of mebendazole in the second trimes-
ter per Ugandan Ministry of Health guidelines. Partici-
pants received their routine medical care at the study 
clinic and had routine laboratory assessments completed 
every 4  weeks. Enrollees were encouraged to deliver at 
the study site hospital.
Clinical outcomes
Mothers were evaluated throughout pregnancy for 
Plasmodium parasitaemia beginning at enrolment (12–
20  weeks of gestational age), and additionally with rou-
tine monthly surveillance testing peripheral blood via 
loop-mediated isothermal amplification (LAMP) kits 
(Eiken Chemical) which detect Plasmodium DNA [18, 
19]. During febrile episodes mothers were evaluated with 
blood microscopy, and if positive, treated per local guide-
lines for clinical malaria, as previously described [18].
At the time of delivery, maternal peripheral blood, pla-
cental blood and cord blood was tested for parasitaemia 
by both LAMP and microscopy. Placental tissue was pro-
cessed for histopathologic evidence of malaria infection, 
determined by standardized placental malaria histopa-
thology criteria as previously described [18, 20, 21].
CBMC collection
At the time of delivery, whole cord blood was collected 
in umbilical cord blood collection kits (Pall Medical). 
Whole blood was additionally collected in EDTA tubes 
for fresh whole cord blood experiments. CBMCs were 
isolated by Ficoll-histopaque density centrifugation (GE 
Life Sciences). CBMCs were cryopreserved in liquid 
nitrogen and transported for analysis in San Francisco, 
CA, USA. Post-thaw CBMC viability was analysed via 
Millipore cell counter and was consistently >78 %.
Flow cytometry immunophenotyping
CBMCs were thawed, aliquoted at 1 × 106 cells, surface 
and intracellularly stained using standard protocols using 
the following antibodies: allophycocyanin/Cy7 (APC/
Cy7)-conjugated CD3 (clone OKT3), peridinin chloro-
phyll protein (PerCP)-conjugated CD4 (clone RPA-T4), 
Brilliant Violet 421-conjugated CD25, Brilliant Violet 
650-conjugated CD127, Brilliant Violet 605-conjugated 
CD45RO, allophycocyanin (APC)-conjugated CCR4, flu-
orescein isothiocyanate (FITC)-conjugated CCR7 (Bio-
Legend), phycoerythrin-Cy7 (PE-Cy7)-conjugated CD95 
(BD Pharmingen), and phycoerythrin (PE)-conjugated 
FoxP3 (eBioscience). Brilliant Violet 510-conjugated 
CD8, Brilliant Violet 510-conjugated CD14, Brilliant Vio-
let 510-conjugated CD19 (BioLegend) and LIVE/DEAD 
aqua amine (Invitrogen) were included to exclude non-
specific binding and to isolate the CD4 cell population. 
To normalize the frequency of analysed CD4 sub-sets 
(Tregs and CD127+ cells) from cryopreserved CBMCs 
to absolute rates of CD4 per microlitre of fresh whole 
cord blood, absolute CD4 sub-set counts were calculated 
(CD4 sub-set frequency * absolute CD4 count per micro-
litre of whole cord blood).
Flow cytometry data were collected on an LSR2 four-
laser flow cytometer (Becton Dikinson) with FACSDiva 
software. Colour compensations were performed using 
compensation beads. Fluorescence-minus-one samples 
were used to define negative and positive populations 
for CD95, CD45RO, CCR4, and CCR7. An isotype con-
trol was used to define negative and positive populations 
for FoxP3 and CD25. Cellular profiles were gated on live 
CD3+CD4+ lymphocytes (Fig. 1).
Absolute whole blood immune cell counts
Dendritic cells and CD4 T cells were enumerated from 
50 μL of whole cord blood stained with antibodies in BD 
TruCount™ tubes or with 20 μL of CountBright™ count-
ing beads (ThermoFisher Scientific). Cells were incu-
bated 20 min, and 900 μL of BD FACS lysis solution was 
added for 15 min. CD4 T cell staining was performed on 
152 cord blood samples using PerCP-conjugated CD3, 
APC-conjugated CD4 antibodies. Dendritic cell staining 
was performed on 145 cord blood samples using FITC-
conjugated Lin-2 (CD3, CD14, CD19, CD20, CD56), 
PE-conjugated CD123, PerCP-conjugated HLA-DR, 
and APC-conjugated CD11c (BD Pharmingen). Cells 
were immediately analysed on an Accuri A6 cytom-
eter. Dendritic cells were defined as Lin-2−HLA-DR+, 
myeloid dendritic cells were defined as Lin-2−HLA-
DR+CD11c+CD123−, plasmacytoid cells were defined as 
Lin-2−HLA-DR+CD11c−CD123+.
Statistical methods
Statistical analyses were performed using PRISM 6.0 
(GraphPad) and STATA 13.1 (StataCorp). Non-paramet-
rically distributed cellular frequencies were log-trans-
formed for normalization. Associations between in utero 
malaria exposure and cellular frequencies were compared 
using the Wilcoxon rank sum and/or Student’s t test as 
appropriate. Associations between continuous variables 
were compared using Spearman’s rank correlation (rs). 
Two-sided p values were calculated for all test statistics, 
and p < 0.05 was considered significant.
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Results
Study cohort and pregnancy‑associated malaria outcomes
The study cohort consisted of 166 infants born to moth-
ers enrolled in a clinical trial of artemisinin-based pre-
natal malaria chemoprevention. Women were enrolled 
at 12–20  weeks of gestation and evaluated monthly 
for parasitaemia by LAMP until delivery. Overall 79  % 
(131/166) of enrollees had some evidence of pregnancy-
associated malaria (any Plasmodium detected during 
pregnancy or delivery). At the time of enrolment, 54 % 
of mothers were parasitaemic by LAMP, suggesting a 
high burden of infection early in pregnancy. Based on 
routine monthly surveillance, 49 % of mothers were par-
asitaemic by LAMP at least once after enrolment and 
prior to delivery. At delivery, placental specimens were 
assessed for evidence of PM by histopathology (using 
standardized criteria by Rogerson et al. [21]), placental 
blood microscopy, and placental blood LAMP. Histo-
pathologic evidence of infection was observed in 38  % 
(63/166) of placentas, but only 12 % (20/166) of placen-
tal blood samples were positive by LAMP (Table 1). The 
majority of placentas with histopathologic evidence of 
malaria infection had only pigment deposition without 
parasites, inflammatory infiltrate, or positive LAMP, 
suggesting a remote malaria infection. Among women 
randomized to artemisinin-based prenatal chemopre-
vention, the rate of at least one episode of parasitaemia 
during the trial period decreased by fourfold (p < 0.001), 
the rate of histopathologic evidence of infection was 
decreased by twofold (p =  0.001), and the rate of pla-
cental blood LAMP infection decreased by sixfold 
(p < 0.001) [18].
Cord blood FoxP3+ Treg counts are higher in infants born 
to mothers with parasitaemia early in pregnancy
Elevated frequencies of cord blood T regulatory cells 
have been reported among infants born to mothers with 
PM in some, but not all, prior studies [7–12]. A stringent 
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Fig. 1 Flow cytometry gating strategy. Flow cytometric analysis of cord blood live CD4+CD25+ T cells revealed two distinct sub-populations based 
on FoxP3 and CD127 expression, T regulatory (CD4+CD25+FoxP3−CD127lo/−) and CD127+ (CD4+CD25+FoxP3−CD127hi) cells
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definition of T regulatory cells was used, defined as 
CD25+FoxP3+CD127lo/− CD4 T cells (Fig. 1), and com-
pared in utero malaria exposed and unexposed infants. 
Both Treg frequency (as a percentage of all CD4 T cells) 
and the absolute counts of Tregs per microlitre of fresh 
whole cord blood were assessed. Infants born to moth-
ers with parasitaemia by LAMP at the time of enrolment 
(12–20  weeks gestation) had significantly higher abso-
lute counts of Tregs compared with infants whose moth-
ers were not parasitaemic (38.9 vs 31.7 cells/μL whole 
cord blood p =  0.048; Fig.  2). Frequencies of Tregs were 
also higher in this group, although this difference was 
not statistically significant (p  =  0.180). However, there 
was no association between the frequency of Tregs and 
the presence of parasites in the placenta at the time of 
delivery (by LAMP; p  =  0.803). Placental histopathol-
ogy reflects both long-standing chronic malaria infec-
tion, represented by pigment deposition, as well as active 
malaria infection, represented by parasites and inflam-
mation [21]. Both the frequencies and absolute counts 
of Tregs were higher in infants whose mothers had his-
topathologic evidence of infection, but this difference 
was not statistically significant (p = 0.158 and p = 0.069, 
respectively; Fig. 2). Lastly, the frequency of Tregs was not 
associated with the composite outcome of ‘any malaria 
exposure’ during pregnancy or delivery (p = 0.792). Cord 
blood Treg frequency was not associated with gravidity 
(p  =  0.281), prematurity (p  =  0.474), low birth weight 
(p = 0.973), nor with randomized chemoprevention arm 
(p = 0.283). These data suggest that in utero malaria anti-
gen exposure early in pregnancy, but not active placental 
infection late in pregnancy, is associated with an expan-
sion of fetal Tregs.
Frequencies of activated CD127+ CD4 T cells are increased 
in infants with active placental infection
Several prior studies reporting an association between 
regulatory T cells and PM had defined Tregs as all CD4 
T cells with high expression of CD25. However, it is 
now known that CD25 is expressed on a variety of acti-
vated CD4+ cells that lack regulatory function and 
do not express the canonical Treg transcription fac-
tor FoxP3. Using additional Treg markers (CD127 and 
FoxP3), this study found that CD25hi CD4 T cells can be 
sub-divided into two major populations: conventional 
Tregs (CD25+FoxP3+CD127lo/−) and putatively activated 
CD127+ CD4 T cells (CD25+Foxp3−CD127+; Fig. 1). This 
latter population phenotypically resembles effector mem-
ory T cells (TEM) which have recently been described 
in healthy fetuses even in the absence of any infectious 
exposures [22]. Notably, infants with active placental 
LAMP infections had significantly higher frequencies of 
these activated CD127+ cells (p = 0.035; Fig. 3). However, 
the frequency of activated CD127+ cells was not elevated 
in infants born to mothers with histopathologic evidence 
of PM (p = 0.656), parasitaemia at enrolment (p = 0.752), 
or in infants born to mothers with parasitaemia between 
20 and 40 weeks of gestation (p =  0.315). Furthermore, 
the frequency of activated CD127+ cells in cord blood 
was not associated with gravidity (p = 0.951), prematu-
rity (p =  0.455), low birth weight (p =  0.405), nor with 
randomized chemoprevention arm (p = 0.339). Together, 
these data suggest that in utero malaria exposure early 
in pregnancy may drive a regulatory response, while late 
exposure to parasites present at the time of delivery may 
drive an activated effector CD4 T cell response.
Table 1 Cohort characteristics and malaria outcomes
u Loop-mediated isothermal amplification
Maternal characteristics n (%)
Total enrollees 166
Maternal age (mean) 22.1
Previous pregnancies (%)
 0 56 (33.7)
 1 51 (30.7)
 2 or more 59 (35.5)
Randomized chemoprevention arm
 Dihydroartemisinin-piperaquine 86 (51.8)
 Sulfadoxine-pyrimethamine 80 (48.2)
Malaria outcomes Positive n (%)
Assessments during pregnancy
 LAMPu at enrolment 89 (53.6)
 Any LAMP during monthly screening 81 (48.8)
Assessments at delivery
 Maternal peripheral blood
  Microscopy 4 (2.4)
  LAMP 20 (12.1)
Placental blood
 Microscopy 4 (2.4)
 LAMP 20 (12.1)
Cord blood
 Microscopy 0 (0)
 LAMP 3 (1.8)
Histopathology 63 (38.0)
 Parasites, pigment in monocytes ± fibrin 4 (2.4)
 Pigment only 59 (35.5)
Any malaria during pregnancy or delivery 131 (78.9)
Infant outcomes n (%)
Preterm (<37 weeks) 9 (5.4)
Low birth weight (<2500 g) 9 (5.4)
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Cord blood activated CD127+ CD4 T cells exhibit evidence 
of effector memory differentiation
Given their divergent associations with early and 
late gestation infections, additional cell surface 
markers were assessed to further distinguish Tregs 
(CD25+FoxP3+CD127lo/−) and activated CD127+ 
(CD25+FoxP3−CD127hi) sub-sets of cord blood CD25+ 
CD4 T cells. While the majority of cord blood CD4 T 
cells, as well as the Treg (CD25+FoxP3+CD127lo/−) sub-
set, were CD45RO−CCR7+, indicating a naïve pheno-
type, most activated CD127+ cells had up-regulated 
CD45RO and down-regulated CCR7 expression (Fig. 4), 
suggesting effector-memory differentiation. In addition 
to down-regulation of the lymph node migration marker 
CCR7, activated CD127+ CD4 T cells exhibited striking 
up-regulation of CCR4, a cell surface marker that has 
been associated with Th2 differentiation, as well as up-
regulation of CD95, a cell surface protein that mediates 
apoptosis (Fig. 4c). Thus, Tregs (CD25+FoxP3+CD127lo/−) 
and activated CD127+ (CD25+FoxP3−CD127hi) CD4 T 
cells exhibited markedly distinct expression of several 
cell surface molecules (Fig. 4d). Based on their memory 
phenotype differentiation, up-regulation of CD95, and 
expansion in infants with active placental malaria infec-
tion, these data suggest that CD127+ CD4 T cells may be 
an antigen-experienced effector memory cell population.
Myeloid dendritic cell counts are higher in cord blood 
of infants with histopathologic evidence of PM
The role of antigen-presenting cells was additionally 
investigated as a potential contributor to the induction of 
regulatory immune responses. Given the role of dendritic 
cells in T cell priming [23] and tolerance [24], The abso-
lute count of myeloid and plasmacytoid dendritic cell 
(mDC and pDC) sub-sets in whole cord blood was meas-
ured from 145 infants. Total dendritic cell counts were 
higher among infants born to mothers with histopatho-
logic evidence of PM (p  =  0.018). This difference was 
driven by higher mDC counts among histopathologic 
PM-exposed infants (p  <  0.0001), as pDC counts were 
not significantly different (p = 0.139; Fig. 5). Active pla-
cental infection (LAMP positive) was not associated with 
changes in dendritic cell counts, indicating that dendritic 
cell expansion is more pronounced following remote 
infection rather than late-gestation infection.
Additionally, the association of dendritic cell sub-sets 
with regulatory and effector CD4 T cell subsets. pDC 
counts were positively associated with both absolute Treg 
counts (p =  0.0139, rs 0.204) and absolute CD127+ cell 
counts (p =  0.027, rs 0.183). mDC counts were not sig-
nificantly associated with either CD4 sub-set.
Discussion
Investigations from the presented longitudinal study 
detail the relationship of cord blood regulatory and acti-
vated CD4 T cells to in utero malaria exposure. Findings 
include that while Tregs were higher among infants with 
early/remote malaria exposure, active placental infection 
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with persistence of plasmodial DNA at the time of deliv-
ery was associated with expansion of activated CD127+ 
CD4 T cells resembling effector memory T cells. mDC, 
critical for T cell priming, were also expanded in PM-
exposed infants. These findings suggest that in utero 
exposure to malaria impacts both fetal T cells and anti-
gen presenting cells, and the timing of malaria infections 
during pregnancy may have a pivotal role in determining 
the polarization of the infant immune response.
The role of FoxP3+ regulatory CD4 T cells in PM infec-
tion has been controversial. Some studies have found 
elevated cord blood Treg frequencies in the setting of PM 
[9–11], while others have found no association [7, 8, 12]. 
Depletion of CD4+CD25+ T cells (putative Tregs) has 
been shown to abrogate malaria specific T-cell cytokine 
production, suggesting that Tregs play a functionally sup-
pressive role in malaria-exposed infants, regardless of 
whether they are increased in frequency [10].
The longitudinal design of this study provides insight 
on the effects of timing and type of malaria exposure on 
fetal Treg induction. Cord blood Tregs were associated with 
maternal parasitaemia early in pregnancy (12–20  weeks 
gestation), but not with composite malaria exposure (any 
malaria exposure during gestation) or acute placental 
infection. Among prior studies assessing the association 
of Tregs with in utero malaria exposure, many evaluated 
malaria exposure only at the time of delivery. However, 
women in highly endemic regions can develop PM early 
in pregnancy and often experience repeated episodes 
of malaria parasitaemia during pregnancy and at deliv-
ery. Moreover, fetal immune development is a dynamic 
process. High levels of Treg cells are present in the fetal 
thymus and fetal lymph nodes at 12–20 weeks of gesta-
tion [25] and mid-gestation T cells are particularly pre-
disposed to differentiate into tolerogenic Tregs following 
stimulation by antigen [16]. Exposure to malaria antigens 
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+ cells in one representative cord blood sample
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during this critical window of immune development 
could explain the expansion of T regulatory cells follow-
ing early gestational exposure to malaria antigens.
The definition of T regulatory cells differed greatly 
among earlier studies, and these differences may have 
contributed to conflicting findings. For instance, several 
studies defined Tregs as all CD4+CD25hi cells, but it has 
since been appreciated that FoxP3 expression correlates 
with suppressive function. Prior studies that used less 
precise definitions (e.g., without assessing expression of 
transcription factor FoxP3) found associations with in 
utero malaria exposure [9–11]. In contrast, most stud-
ies with more stringent definitions of Tregs (including 
assessment for FoxP3 expression) did not find associa-
tion between frequency of cord blood Tregs and in utero 
malaria exposure [7, 8, 12]. This study found that CD25hi 
CD4 T cells can be sub-divided into two distinct popu-
lations, FoxP3+ Tregs, which have low CD127 expression, 
and CD127+ cells which lack FoxP3 expression. Prior 
studies that associated PM with increased frequencies of 
CD4+CD25+ cord blood cells would have been unable to 
differentiate FoxP3+ Tregs from the activated cord blood 
CD127+ CD4 T cell population that were found to be 
expanded among infants with active placental infection.
An activated CD127+ CD4 T cell cord blood popula-
tion was observed that phenotypically resembles the 
T effector memory (TEM) cells recently described by 
Zhang et al. [22]. These TEM cells were shown to have a 
polyclonal T-cell receptor repertoire, exhibit proliferative 
capacity, and be poised for inflammatory cytokine pro-
duction, although they developed in a presumably sterile 
intra-uterine environment [22]. The expansion of acti-
vated TEM-like CD127+ cells in neonates with active pla-
cental infection raises the possibility that these cells may 
have specificity for malaria antigens, which are known 
to cross into the fetal circulation during pregnancy-
associated malaria [26, 27]. However, further studies are 
needed to determine whether these are malaria-specific. 
Prior studies evaluating fetal CD127+ CD4 T cells have 
not found an association with malaria exposure, but in 
these studies PM was diagnosed based only on less sensi-
tive blood smears [8, 11]. In this study, activated CD127+ 
CD4 cells were found to highly up-regulate CCR4, which 
has been classically associated with Th2 differentia-
tion. However, cord blood CD4+ effector cells are more 
ambiguous in their Th differentiation and may defy clas-
sic Th sub-set differentiation described in adults [22].
Additional findings include that PM exposure was 
strongly associated with an expansion of cord blood mDCs, 
which play a central role in priming T cell responses. Plas-
modium falciparum is known to modulate DC function 
and maturation, leading to decreased expression of mat-
uration, cell adhesion and co-stimulatory markers. The 
resulting immature, or ‘tolerized’ DCs have a diminished 
capacity to activate effector T cells [28]. These results con-
cur with a prior study of Gabonese infants, which found 
elevated cord blood mDCs but not pDCs in malaria-
exposed infants [29]. However, a more recent study assess-
ing cord blood mDCs and pDCs in malaria-exposed 
infants found no association with PM [30]. In vitro studies 
of cord blood have shown that dendritic cells can induce 
Treg differentiation [31] and pDCs induce Tregs from CD4 
T cells [32, 33] with greater induction capacity than mDCs 
[24, 34]. In the present study, although pDC counts were 
not associated with malaria outcomes, they were positively 
associated with absolute Treg and absolute CD127+ cord 
blood counts. Further mechanistic evaluations are needed 
to delineate fetal dendritic and T cell interactions follow-
ing in utero malaria exposure.
This study had a few notable limitations. First, malaria 
exposure prior to 12–20 weeks gestation was not assessed 
and thus the effect of very early in utero malaria exposure 
on fetal immune system development was not evaluated. 
In addition, the study was performed in a very high trans-
mission region; more than half of the pregnant women 
were parasitaemic at the time of enrolment, and malaria 
infection was documented at some point in pregnancy or 
at delivery in nearly 80 % of subjects. Thus, the findings 
may not be generalizable to settings with lower transmis-
sion intensity and/or lower levels of pre-existing maternal 
immunity. Perhaps as a result of this high exposure inten-
sity, most placentas showing histopathologic evidence of 
PM were categorized as ‘past’ rather than ‘active-acute’ 
infection [21]. This high ratio of past to active cases of 
PM may have been influenced by the use of intermittent 
preventive treatment in pregnancy (IPTp), as subjects 
in this study were enrolled in a chemoprevention trial; 
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Fig. 5 Myeloid dendritic cell counts are higher in placental 
histopathologic malaria infection. Absolute counts of total den-
dritic cells (Lin−HLA-DR+) (DCs), myeloid dendritic cells (Lin−HLA-
DR+CD11c+CD123−) (mDCs), and plasmacytoid dendritic cells 
(Lin-HLA-DR+CD11c−CD123+) (pDCs) in cord blood of infants with 
negative and positive histopathology for placental malaria (Wilcoxon 
rank sum; n = 145)
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however, randomized treatment arm was not associated 
with any immunologic outcome measures. In study set-
tings where more late-gestation PM infections occur, the 
impact on fetal T cell development may differ. Lastly, a 
number of immunologic and exposure outcomes were 
evaluated simultaneously and data were reported with-
out adjustment for multiple comparisons introducing the 
potential for α-error inflation. Additional studies will be 
needed in order to validate these findings, and to deter-
mine whether the activated CD4 T cells described here 
represent malaria-specific responses.
Conclusions
In summary, significant heterogeneity in T cell pheno-
types were found to be related to the timing of in utero 
malaria exposure. Tregs were modestly increased in 
infants exposed to malaria early in gestation, whereas 
activated CD127+ CD4 T cells of an effector-memory 
phenotype were expanded in infants with active placental 
infection at the time of delivery. Fetal CD4 T cell differ-
entiation is likely influenced by both the type and timing 
of antigen exposure. Prospective longitudinal studies are 
needed to determine the functional implications of fetal 
regulatory and effector CD4 T cells on the development 
of anti-malarial immunity during childhood.
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